Invea Therapeutics, Inc. (INAI)

Invea Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.6	0.59	0.32
Cash & Cash Equivalents	0.6	0.59	0.32
Cash Growth	-	81.48%	-
Other Current Assets	1.37	0.19	0.07
Total Current Assets	1.97	0.78	0.39
Property, Plant & Equipment	-	0.01	0.01
Total Long-Term Assets	-	0.01	0.01
Total Assets	-	0.79	0.4
Accounts Payable	-	0.5	0.3
Current Debt	-	1.82	-
Other Current Liabilities	8.22	0.57	0.2
Total Current Liabilities	8.22	2.88	0.5
Long-Term Debt	-	-	1.16
Other Long-Term Liabilities	-	0.05	0
Total Long-Term Liabilities	-	0.05	1.16
Total Liabilities	-	2.93	1.66
Total Debt	3.26	1.82	1.16
Debt Growth	-	56.06%	-
Retained Earnings	-	-7.81	-2.05
Shareholders' Equity	-11.99	-7.27	-1.86
Net Cash / Debt	-2.66	-1.23	-0.84
Working Capital	-6.25	-2.1	-0.11

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).